Non-linear association of induction dose with early dropout from methadone maintenance treatment: A retrospective cohort study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 42585946.
- Also identified by DOI 10.1016/j.drugalcdep.2026.113300.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Conservative induction dose in methadone maintenance treatment (MMT) may lead to early dropout. Existing evidence mostly focuses on linear associations, leaving non-linear dose-response relationships and critical inflection points unexplored. This retrospective cohort study analyzed 5083 first-time patients across 11 MMT clinics in Guangdong Province (2006-2021). The mean methadone dose in the first week defined the induction dose, and dropout within 30 days was the outcome. Restricted Cubic Spline (RCS) and threshold analysis explored non-linear and inflection points. After confounder adjustment, a significant negative association existed between dose and dropout (OR=0.900, 95% CI: 0.876-0.924), confirmed with weighting. A non-linear relationship was identified (P<sub>non-linear</sub> <0.001) with an inflection point at 40.71mg/day. Below this point, each 5mg/day dose increase reduced dropout risk by 17% (OR=0.83, 95% CI: 0.78-0.87). Above 40.71mg/day, the risk reduction was 6% (OR=0.94, 95% CI: 0.91-0.98). Sensitivity analysis (excluding 48 high doses) lowered the inflection point to 33.57mg/day. Subgroup analysis indicated interactions of the induction dose effect with both drug-use frequencies (P = 0.043) and the year entering MMT (P = 0.027). Those with higher drug frequency showed a smaller reduction in dropout risk after increasing the induction dose. The study identified a non-linear association between induction dose and early dropout, and there is a threshold effect inflection point. Based on current guidelines, there is a need to appropriately increase the starting dose of MMT, with further consideration of methadone safety and individual differences required in clinical practice.